ORIC Pharmaceuticals, Inc. (ORIC) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

ORIC Pharmaceuticals, Inc. (ORIC) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

ORIC Income Statement

ORIC Pharmaceuticals, Inc. (ORIC) annual income statement — 9-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	264K	0	320K	0	0	0	304K	0	0	261K	263K	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-264K	0	-320K	0	0	0	-304K	0	0	-261K	-263K	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-5.26%	-	-	100%	-15.59%	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	45.03M	39.62M	34.23M	36.67M	39.06M	32.72M	39.27M	38.32M	36.02M	28.73M	31.16M	28.68M	24.99M	25.68M	22.12M	25.69M	20.7M	23.26M	22.8M	18.46M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	9M	8.18M	8.7M	7.9M	8.52M	8.08M	7.3M	7.12M	7.08M	6.77M	6.68M	6.29M	6.21M	6.16M	5.82M	5.97M	6.86M	6.43M	6.06M	5.56M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	36.3M	31.44M	25.86M	28.77M	30.55M	24.64M	31.97M	31.2M	28.94M	21.96M	24.48M	22.39M	18.79M	19.52M	16.3M	14.72M	13.83M	16.83M	16.75M	12.9M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-264K	0	-320K	0	0	0	0	0	0	0	0	0	0	0	0	1000K	0	0	0	0
Operating Income	-45.3M	-39.62M	-34.55M	-36.67M	-39.06M	-32.72M	-39.57M	-38.32M	-36.02M	-28.99M	-31.43M	-28.68M	-24.99M	-25.68M	-22.12M	-25.69M	-20.7M	-23.26M	-22.8M	-18.46M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-15.95%	-21.09%	12.68%	4.3%	-8.46%	-12.86%	-25.91%	-33.6%	-44.11%	-12.9%	-42.09%	-11.63%	-20.76%	-10.41%	3.01%	-39.22%	1.71%	-40.51%	19.37%	27.91%
EBITDA	-45.03M	-39.35M	-34.23M	-36.38M	-38.75M	-32.42M	-39.27M	-38.05M	-35.74M	-28.73M	-31.16M	-28.43M	-24.73M	-25.43M	-21.87M	-25.47M	-20.45M	-23.01M	-22.58M	-18.24M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-16.2%	-21.39%	12.82%	4.38%	-8.42%	-12.83%	-25.99%	-33.85%	-44.52%	-13%	-42.49%	-11.59%	-20.95%	-10.51%	3.12%	-39.66%	1.85%	-40.94%	19.51%	28.09%
D&A (Non-Cash Add-back)	264K	270K	320K	288K	310K	302K	304K	270K	272K	261K	263K	257K	259K	253K	247K	221K	247K	251K	229K	217K
EBIT	-45.3M	-35.77M	-30.5M	-32.59M	-36.35M	-30.02M	-36.31M	-34.57M	-31.96M	-25.01M	-28.33M	-28.68M	-24.99M	-25.68M	-22.12M	-20.69M	-20.7M	-23.26M	-22.8M	-18.46M
Net Interest Income	0	0	0	0	0	0	0	0	4.05M	3.98M	1.11M	3.2M	2.05M	1.73M	1.27M	865K	409K	99K	34K	30K
Interest Income	0	0	0	0	0	0	0	0	4.05M	3.98M	3.1M	3.2M	2.05M	1.73M	1.27M	865K	409K	99K	34K	30K
Interest Expense	0	0	0	0	0	0	0	0	0	0	1.99M	0	0	0	0	0	0	0	0	0
Other Income/Expense	3.8M	3.85M	4.05M	4.08M	2.71M	2.7M	3.26M	3.75M	4.05M	3.98M	3.1M	3.2M	2.05M	1.73M	1.27M	865K	409K	99K	34K	30K
Pretax Income	-41.49M	-35.77M	-30.5M	-32.59M	-36.35M	-30.02M	-36.31M	-34.57M	-31.96M	-25.01M	-28.33M	-25.48M	-22.94M	-23.95M	-20.85M	-24.83M	-20.29M	-23.16M	-22.77M	-18.43M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-41.49M	-35.77M	-30.5M	-32.59M	-36.35M	-30.02M	-36.31M	-34.57M	-31.96M	-25.01M	-28.33M	-25.48M	-22.94M	-23.95M	-20.85M	-24.83M	-20.29M	-23.16M	-22.77M	-18.43M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-14.13%	-19.14%	15.98%	5.73%	-13.74%	-20.03%	-28.16%	-35.67%	-39.31%	-4.45%	-35.89%	-2.61%	-13.1%	-3.39%	8.45%	-34.75%	3.44%	-40.28%	19.42%	27.88%
Net Income (Continuing)	-41.49M	-35.77M	-30.5M	-32.59M	-36.35M	-30.02M	-36.31M	-34.57M	-31.96M	-25.01M	-28.33M	-25.48M	-22.94M	-23.95M	-20.85M	-24.83M	-20.29M	-23.16M	-22.77M	-18.43M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.38	-0.34	-0.30	-0.33	-0.47	-0.42	-0.51	-0.49	-0.45	-0.37	-0.49	-0.44	-0.50	-0.53	-0.52	-0.63	-0.51	-0.59	-0.58	-0.47
EPS Growth %	19.15%	19.05%	41.18%	32.65%	-4.44%	-13.51%	-4.08%	-11.36%	10%	30.19%	5.77%	30.16%	1.96%	10.17%	10.34%	-34.04%	10.53%	-31.11%	30.95%	44.05%
EPS (Basic)	-0.38	-0.34	-0.30	-0.33	-0.47	-0.42	-0.51	-0.49	-0.45	-0.37	-0.49	-0.44	-0.50	-0.53	-0.52	-0.63	-0.51	-0.59	-0.58	-0.47
Diluted Shares Outstanding	108.01M	105.47M	87.79M	98.95M	78.13M	71.04M	70.65M	70.54M	70.35M	67.35M	57.46M	57.4M	45.65M	45.09M	40.13M	39.58M	39.48M	39.43M	39.39M	39.01M
Basic Shares Outstanding	108.01M	105.47M	87.79M	98.95M	78.13M	71.04M	70.65M	70.54M	70.35M	67.35M	57.46M	57.4M	45.65M	45.09M	40.13M	39.58M	39.48M	39.43M	39.19M	39.01M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-